Assessment of ovarian reserve with anti-Müllerian hormone: a comparison of the predictive value of anti-Müllerian hormone, follicle-stimulating hormone, inhibin B, and age

Objective The objective of this study was to evaluate basal anti-Müllerian hormone as a marker for ovarian responsiveness to fertility treatment. Study Design Frozen basal menstrual cycle day 3 serum samples were evaluated retrospectively for anti-Müllerian hormone, inhibin B, and follicle-stimulating hormone levels in 123 in vitro fertilization cycles (93 patients) and compared with in vitro fertilization records. Results Anti-Müllerian hormone values correlated the best with the number of retrieved oocytes ( r = 0.539; P < .001) relative to age ( r = −0.323; P < .01), follicle-stimulating hormone ( r = −0.317; P < .01), inhibin B ( P > .05), luteinizing hormone ( P > .05), and estradiol ( r = −0.190; P < .05). Receiver operating characteristic curve analysis demonstrated that, for the prediction of .05). Similarly, for the prediction of ≥15 retrieved oocytes, anti-Müllerian hormone had the largest area under the curve (0.80; P = .0001) relative to age (0.63; P = .02), follicle-stimulating hormone (0.64; P = .005), inhibin B ( r = 0.57; P > .05), and estradiol (0.58; P > .05). Conclusion Anti-Müllerian hormone correlates better than age, follicle-stimulating hormone, luteinizing hormone, inhibin B, and estradiol with the number of retrieved oocytes. Receiver operating characteristic curves estimated that anti-Müllerian hormone accurately predicts ovarian responsiveness to controlled ovarian stimulation with high sensitivity and specificity.